Efficient Plasma Cell Differentiation and Trafficking Require Cxcr4 Desensitization  by Biajoux, Vincent et al.
ArticleEfficient Plasma Cell Differentiation and Trafficking
Require Cxcr4 DesensitizationGraphical AbstractHighlightsd Cxcr4 desensitization controls plasma cell differentiation
d Cxcr4 desensitization inhibits plasmablast accumulation in
the bone marrow
d Cxcr4 desensitization is required for antigen-specific plasma
cell trafficking
d Cxcr4 desensitization is required for maintaining antigen-
specific antibody titersBiajoux et al., 2016, Cell Reports 17, 193–205
September 27, 2016 ª 2016 The Author(s).
http://dx.doi.org/10.1016/j.celrep.2016.08.068Authors
Vincent Biajoux, Jessica Natt,
Christelle Freitas, ..., Nicolas Fazilleau,
Marion Espe´li, Karl Balabanian
Correspondence
marion.espeli@u-psud.fr (M.E.),
karl.balabanian@u-psud.fr (K.B.)
In Brief
Using a mouse model harboring a gain-
of-function mutation in Cxcr4, Biajoux
et al. show that Cxcr4 desensitization is a
crucial regulatory mechanism controlling
plasma cell differentiation and trafficking.
This mutation is associated with an
accumulation of plasmablasts in the bone
marrow and defective maintenance of
serum antibody titers.
Cell Reports
ArticleEfficient Plasma Cell Differentiation
and Trafficking Require Cxcr4 Desensitization
Vincent Biajoux,1,6 Jessica Natt,1,6 Christelle Freitas,1 Nagham Alouche,1 Antoine Sacquin,2,3,4 Patrice Hemon,5
Franc¸oise Gaudin,1 Nicolas Fazilleau,2,3,4 Marion Espe´li,1,* and Karl Balabanian1,7,*
1INSERM UMR996 – Inflammation, Chemokines and Immunopathology, Universite´ Paris-Sud and Universite´ Paris-Saclay, Clamart 92140,
France
2INSERM U1043, Toulouse 31300, France
3CNRS U5282, Toulouse 31300, France
4Centre de Physiopathologie de Toulouse Purpan, Universite´ Toulouse III Paul-Sabatier, Toulouse 31300, France
5Plateforme d’Histologie (PHIC), Institut Paris-Saclay d’Innovation The´rapeutique (IPSIT), Clamart 92140, France
6Co-first author
7Lead Contact
*Correspondence: marion.espeli@u-psud.fr (M.E.), karl.balabanian@u-psud.fr (K.B.)
http://dx.doi.org/10.1016/j.celrep.2016.08.068SUMMARY
CXCR4 plays a central role in B cell immune
response, notably by promoting plasma cell (PC)
migration and maintenance in the bone marrow
(BM). Gain-of-function mutations in CXCR4 affecting
receptor desensitization have been reported in
the rare immunodeficiency called WHIM syndrome
(WS). Despite lymphopenia, patients mount an im-
mune response but fail to maintain it over time. Using
a knockin mouse model phenocopying WS, we
showed that, counter-intuitively, a gain of Cxcr4
function inhibited the maintenance of antibody titers
after immunization. Although the Cxcr4 mutation
intrinsically and locally promoted germinal center
response and PC differentiation, antigen-specific
PCs were barely detected in the BM, a defect
mirrored by early accumulation of immature plas-
mablasts potentially occupying the survival niches
for long-lived PCs. Therefore, fine-tuning of Cxcr4
desensitization is critically required for efficient PC
differentiation and maintenance, and absence of
such a regulatory processmay account for the defec-
tive humoral immunity observed in WS patients.
INTRODUCTION
The warts, hypogammaglobulinemia, infections, and myeloka-
thexis syndrome (WS) is a rare combined immuno-hematologic
disorder characterized by chronic pan-leukopenia, including
circulating B and T lymphocytes (Dotta et al., 2011; Kawai
and Malech, 2009). Despite this, patients show limited suscep-
tibility to pathogens, with the notable exception of human papil-
lomavirus and respiratory encapsulated bacteria (Kawai and
Malech, 2009). Cellular and humoral immune responses are
largely intact after immunization, but oligoclonality, impaired
memory B cell function, and vaccination failures have been re-Cell Re
This is an open access article undported (Gulino et al., 2004; Handisurya et al., 2010; Mc Guire
et al., 2010). Together these suggest preserved short-term
adaptive immune responses but a defect in the durability of
protective memory humoral responses. The mechanisms
underlying these defects in adaptive immunity are largely
unknown.
An important advance in our understanding of the pathogen-
esis of the WS was the discovery that most WS cases were
associated with a heterozygous gain-of-function mutation in
the gene encoding the G-protein-coupled seven-span trans-
membrane receptor CXCR4, resulting in dysfunction of the
signaling axis formed by CXCR4 and its chemokine CXCL12
(Balabanian et al., 2005; Hernandez et al., 2003). This allowed
the WS phenotype to be replicated in a knockin mouse model
harboring a WS-associated heterozygous mutation in Cxcr4
(Cxcr4+/1013), causing a distal truncation of the last 15 residues
in the carboxyl-terminal tail (C-tail) and resulting in a desen-
sitization-resistant receptor (Balabanian et al., 2012). Mutant
mice displayed leukocytes with enhanced migration to
Cxcl12 and phenocopied the severe circulating pan-leukopenia.
Furthermore, impaired Cxcr4 desensitization was shown to
affect the trafficking of mature lymphocytes between blood-
stream and secondary lymphoid organs (LOs) (Balabanian
et al., 2012). Indeed, Cxcr4+/1013 mice displayed a splenic follic-
ular hypoplasia without alteration of lymphocyte compartmen-
talization, whereas their lymph node (LN) architecture was
disrupted with an unfurling of the T cell zone within primary B
cell follicles. Despite this, serum immunoglobulin M (IgM) and
IgG levels were increased in non-manipulated mutant mice
compared to their wild-type (WT) littermates, suggesting alter-
ations in the quality and control of the humoral immune
response in this model.
Current understanding of the role of Cxcl12 and Cxcr4 in
lymphocyte biology is largely inferred from loss-of-function
studies performed using constitutive or conditional mice defi-
cient for Cxcr4 and Cxcr4/ chimeras (Bannard et al., 2013;
Ma et al., 1998; Nie et al., 2004; Tachibana et al., 1998). The
Cxcl12/Cxcr4 pair is thought to regulate the lymphoid trafficking
of T cells and orchestrate B cell homing, maturation, andports 17, 193–205, September 27, 2016 ª 2016 The Author(s). 193
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Lymphocyte-AutonomousDefects
Lead to Lymphopenia in Cxcr4+/1013Mice
(A) Quantifications of naive (CD44–CD62Lhigh)
and effector/memory (Eff/Mem, CD44high) CD4+
T cells, immature (Immat., B220+IgMhighCD21low)
and mature (Mat., B220highIgMlowCD21high) B cells
were determined from blood samples of WT and
Cxcr4+/1013 (+/1013) mice.
(B) Schematic diagram for the generation of BM
chimeras.
(C and D) Quantifications of donor CD45.2+ (C, WT
or +/1013) or CD45.1+ (D,WT) CD4+ T and B220+ B
cells recovered from the blood, spleen, and LN
of BM chimeras in CD45.1+ (C, WT) or CD45.2+
(D, WT or +/1013) recipients, respectively. Results
are from three independent experiments (mean ±
SEM, A: n = 5–9, C and D: n = 5). *p < 0.05, **p <
0.005, and ***p < 0.0005, as compared with WT or
donor CD45.2+ WT cells.
See also Figure S1.differentiation in secondary LOs as well as direct plasma cells
(PCs) toward specific niches in secondary LOs and bonemarrow
(BM) (Allen et al., 2004; Bannard et al., 2013; Hargreaves et al.,
2001; Nie et al., 2004; Okada et al., 2002; Victora et al., 2010).
In this work, we took advantage of our original and relevant
Cxcr4+/1013 knockin model to explore the biological impact of a
gain-of-function Cxcr4 mutation on germinal center (GC) forma-
tion and primary and memory vaccine responses, as well as on
PC differentiation and trafficking.
RESULTS
A Gain of Cxcr4 Function in B and T Cells Is Sufficient to
Induce a Peripheral Lymphopenia
In-depth analysis of the blood compartment in non-manipu-
lated WT and Cxcr4+/1013 mice revealed that mutant mice
harbored a severe lymphopenia predominantly affecting naive
CD4+ T cells and mature recirculating B cells (Figure 1A).
Similar to the immunophenotype of WS patients (Gulino et al.,
2004), numbers of immature B cells and effector/memory
CD4+ T cells were less affected. Cxcr4 is expressed widely,
and so we next sought to determine whether this circulating
lymphopenia and abnormal lymphocyte compartmentalization194 Cell Reports 17, 193–205, September 27, 2016in secondary LOs from Cxcr4+/1013
mice was due to a lymphocyte-intrinsic
defect or an alteration of the LO micro-
environment. First, BM cells from WT or
Cxcr4+/1013 CD45.2+ mice were used to
reconstitute the hematopoietic compart-
ment of lethally irradiated WT CD45.1+
recipients (Figure 1B, top). Eleven weeks
after reconstitution, there were signifi-
cantly lower numbers of CD4+ T and
B cells in the blood of Cxcr4+/1013
BM-chimeric mice than in those of WT
chimeras (Figure 1C, left panel). B cell
numbers were also reduced in the
spleen and LNs of Cxcr4+/1013 BM-chimeric mice (Figure 1C, middle and right panels). By compar-
ison, as has already been observed in non-manipulated mice
(Balabanian et al., 2012), the number of CD4+ T cells was com-
parable in the spleen of both groups of chimeras and was
increased in the LNs of Cxcr4+/1013 BM chimeras. Competitive
reconstitution experiments in which BM cells from Cxcr4+/1013
CD45.2+ mice were mixed at a ratio of 1:1 with WT CD45.1+
BM cells and transplanted into lethally irradiated WT CD45.1+
recipients confirmed these findings (Figures S1A and S1B). In
these mixed chimeras, fewer Cxcr4+/1013 B cells, and to a
lesser extent CD4+ T cells, were recovered from the blood,
spleen, and LNs.
Then, we performed reverse chimeras where CD45.2+WT and
Cxcr4+/1013 mice were irradiated and reconstituted with WT
CD45.1+ BM (Figure 1B, bottom). Here, the numbers of B cells
and CD4+ T cells were comparable in both experimental groups
in blood and LOs (Figure 1D). Finally, we generated chimeras by
irradiating sub-lethally mMT mice, characterized by the almost
complete absence of B cells, and then reconstituting them with
Cxcr4+/1013 or WT BM (Figure S1C). In these chimera, the gain-
of-function mutation in Cxcr4 is mostly present in B cells. As
expected, Cxcr4+/1013 BM-chimeric mice had normal splenic
CD4+ T cell counts but a marked splenic B cell lymphopenia
(Figure S1D). Overall, these results indicate that the peripheral
B cell lymphopenia observed in Cxcr4+/1013 mice results from a
cell-intrinsic defect in Cxcr4-mediated signaling.
Cxcr4+/1013 Mice Mount a Robust Ag-Specific Immune
Response Despite Disorganized LN Architecture
We next sought to determine whether the severe circulating
T- and B cell lymphopenia and absence of primary B cell follicles
in the LNs impaired the antibody (Ab) response to a thymus-
dependent (TD) antigen (Ag). Cxcr4 signaling in B cells is
involved in GC organization and responses (Allen et al., 2004;
Bannard et al., 2013), we thus assessed the extent to which
the gain-of-function Cxcr4 mutation affected B cell differentia-
tion and humoral immunity in draining (i.e., inguinal) LNs after
subcutaneous immunization with ovalbumin (OVA) emulsified in
Sigma adjuvant system (SAS). The TD B cell response was as-
sessed at the peak of the response, 14 days after primary immu-
nization and 5days after secondary challenge (boost) (Figure 2A).
As expected, we detected the formation of peanut agglutinin
(PNA)-positive GCs, which are microanatomical sites of B cell
expansion, hypermutation, and selection (Liu et al., 1991), after
priming and boosting in WT mice. We also observed PNA-posi-
tive GCs in mutant mice despite the disorganized architecture of
the LNs (Figure 2B). After OVA/SAS priming and boosting, there
was a small reduction in total CD19+ B cells but a similar number
of total GC B cells in LNs fromCxcr4+/1013mice compared toWT
mice (Figure 2C, left and middle panels). There was also a signif-
icant increase in OVA-specific GC B cell numbers in the LNs of
Cxcr4+/1013 mice compared to controls (Figure 2C, right panels).
As GC B cell formation is dependent on Ag-specific CD4+ follic-
ular helper T (Tfh) cells (Vinuesa et al., 2005), we investigated
whether differences in the Tfh-cell subset could account for
this increased representation of OVA-specific GC B cells in
mutant mice. In WT and Cxcr4+/1013 mice, we found no differ-
ences in total CD4+ T cells or Tfh cells (CD4+/CD44+Cxcr5+) after
both priming and boost (Figure 2D).
We then studied the PC compartment in mutant andWTmice,
observing a significant increase in both total and OVA-specific
PCs (CD138highB220low) after priming and boost in Cxcr4+/1013
mice compared toWTmice (Figure 2E). There was also a greater
number of OVA-specific (IgG) antibody-forming cells (AFCs) in
the LNs of immunized Cxcr4+/1013 mice regardless of the time
point as enumerated by ELISpot (Figure 2F). Altogether, these
data indicate that the TD B cell response to a protein Ag is
enhanced locally in the LNs of Cxcr4+/1013 mice.
Cxcr4+/1013 Mice Have Increased Ag-Specific PCs
Despite Splenic Follicular Hypoplasia
Contrary to the LNs, the spleen architecture was preserved
in Cxcr4+/1013 mice; however, the spleen cellularity was much
reduced potentially leading to an altered systemic immune
response (Balabanian et al., 2012). We therefore immunized
WT and Cxcr4+/1013 littermates with 4-hydroxy-3-Nitrophenyla-
cetyl-Keyhole Limpet Hemocyanin (NP-KLH) precipitated in
aluminum hydroxide (Alum) and then quantified the GC reaction
and PC generation at the peak of the response, 9 days after pri-
mary immunization and 7 days after a boost with NP-KLH only
(Figure 3A). The splenic B cell lymphopenia in Cxcr4+/1013 micewas not corrected upon immunization (Figures 3B and 3C). How-
ever, the number of GCB cells was comparable betweenWT and
mutant mice (Figures 3B and 3D, left panel), which suggested
that the immune response is normal in Cxcr4+/1013 mice despite
the B cell lymphopenia. This was particularly obvious when we
calculated the ratio of the number of GC B cells to total B cells
(Figure 3D, middle panel). Moreover, the number of NP-specific
GC B cells was similar between Cxcr4+/1013 and WT mice
(Figure 3D, right panel). We confirmed this increased ratio of
Cxcr4+/1013 GC to total B cells by immunostaining spleens har-
vested 9 days after primary immunization. As shown in Figure 3E,
the B cell follicles (stained with an anti-B220 mAb) were smaller
in Cxcr4+/1013 mice compared to WT littermates, while the GCs
(stained with the PNA lectin) were larger, occupying most of
the follicles. In line with previous reports (Allen et al., 2004;
Bannard et al., 2013), the ratio of dark zone centroblasts
(B220+FAShighGL7highCxcr4highCD86low) to light zone centro-
cytes (B220+FAShighGL7highCxcr4lowCD86high) was increased
in immunized Cxcr4+/1013 mice (Figure 3F). Unlike B cells, there
were only marginally fewer CD4+ T cells in the spleen of
Cxcr4+/1013 mice (Figures 3B and 3C) and the numbers
of Tfh (CD4+PD1highCxcr5highFoxp3-) and follicular regulatory
T (Tfr) cells (CD4+PD1highCxcr5highFoxp3+) were not significantly
different between the mutant andWTmice (Figure 3G), similar to
the observation made in LNs.
We then examined the impact of the gain-of-function mutation
inCxcr4 on PC development. Comparable numbers of PCs were
detected in the spleen of both experimental groups (Figure 3H).
Quantification of splenic AFCs by ELISpot revealed a clear
increase in NP-specific AFCs in immunized Cxcr4+/1013 mice
regardless of the time point (Figure 3I). Affinity maturation, as as-
sessed by the ratio of high- (NP4) and low- (NP15) affinity NP-
specific AFCs, was comparable between WT and Cxcr4+/1013
mice (data not shown). We next wondered whether this
enhanced PC response was associated with an aberrant reten-
tion or localization of PCs in the spleen. As expected (Jacob
et al., 1991; Liu et al., 1991), PCs were mostly observed in the
bridging channels and the red pulp area of both WT and mutant
mice (Figure S2). Of note, PCs in the red pulp ofCxcr4+/1013mice
seem more scattered than in WT mice. This could potentially be
explained by the reduced follicle size observed in absence of
Cxcr4 desensitization (Figures 3E and S2; Balabanian et al.,
2012) and hence the relative expansion of the red pulp in these
mutant mice. These findings suggest that the gain of Cxcr4 func-
tion does not lead to aberrant positioning of newly generated
PCs in the spleen. Finally, we investigated how the enhanced
PC generation observed in absence of Cxcr4 desensitization
affected circulating Ab titers. After a primary immunization,
Cxcr4+/1013 mice mounted an Ab response against NP similar
to that observed in WT mice (Figure 3J). However, this response
waned progressively and was not maintained over time to the
level observed in WT mice. Similarly, WT and Cxcr4+/1013 mice
displayed comparable serum titers of OVA-specific IgG after pri-
mary subcutaneous OVA immunizations despite the differences
in LN OVA-specific PCs (Figures 2E, 2F, and 3K). We also
wondered whether this discrepancy between serum titer and
splenic AFC number could be caused by a defect in Ab secretion
inCxcr4+/1013AFCs. However, we did not observe any differenceCell Reports 17, 193–205, September 27, 2016 195
Figure 2. Cxcr4+/1013 Mice Mount a Robust Ag-Specific Immune Response Despite Disorganized LN Architecture
(A) Representative diagram of the immunization protocol and experimental time points.
(B) Draining lymph nodes (LN) sections from WT and Cxcr4+/1013 mice were obtained before immunization (U/C, unchallenged) or after primary (day 14 after
challenge) and boost (day 5 after boost) subcutaneous immunizations with adjuvanted OVA and stained for CD4, PNA, and IgD. The color code for mAbs or lectin
used is shown. White arrows indicate GC structures. Objective, 103; scale bars represent 500 mm.
(C) Representative dot-plots and numbers of B cells (CD19+CD3–), total (CD19+CD138–FAShighGL7high), and OVA-specific (CD19+CD138–FAShighGL7high
IgD–OVA+) GC B cells were determined from LNs after priming and boost.
(D) Representative dot plots and numbers of CD4+ T cells (CD3+B220–CD8–CD4+) and CD44+CD62L–Cxcr5+ Tfh-enriched cell population.
(E) Representative dot plots and numbers of total (CD19+B220lowCD138high) and OVA-specific (B220lowCD138highIgD–OVA+) PCs.
(F) ELISpot assay of OVA-specific (IgG) AFCs in LNs after challenge or boost immunization. Lines indicate the mean and each circles represent the mean value of
ELISpot triplicates for one mouse.
Results are from three independent determinations (B) or from three independent experiments (C–F) (mean ± SEM, n = 5–6). *p < 0.05 and **p < 0.005, as
compared with WT cells.
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Figure 3. The Gain-of-Cxcr4-Function Mu-
tation Leads to Increased Ag-Specific PC
Generation in the Spleen
(A) Representative diagram of the immunization
protocol and experimental time points.
(B) Representative dot plots for the gating of B
(B220+), CD4 T (CD4+), and GC B (B220+
FAShighGL7high) cells.
(C) Quantification of B and CD4+ T cells in the
spleen of WT and Cxcr4+/1013 mice 9 days (D9)
after primary immunization and 7 days after sec-
ondary immunization (Boost) with NP-KLH.
(D) Quantification of GC B cells (left panel), ratio
of GC B cells over total B cells (middle panel), and
NP-specific GCB cells (right panel) in the spleen of
WT and Cxcr4+/1013 mice.
(E) Representative immunostaining of B cell folli-
cles and GC in the spleen of WT and Cxcr4+/1013
mice 9 days after primary immunization. The color
code for the mAbs used is shown. Objective,320;
scale bars represent 250 mm.
(F) Quantification of the ratio of dark zone
and light zone GC B cells gated as B220+
FAShighGL7highCxcr4highCD86low and B220+FAShigh
GL7highCxcr4lowCD86high, respectively.
(G) Representative dot plot for the gating of Tfh
cells (CD4+Cxcr5highPD1high) and quantification of
Tfh (CD4+Cxcr5highPD1highFoxp3–) and Tfr (CD4+
Cxcr5highPD1highFoxp3+) cells in the spleen of WT
and Cxcr4+/1013 mice.
(H) Representative dot plot for the gating of PCs
(CD138highB220low) and quantification of splenic
PCs.
(I) Frequencies of NP-specific AFCs of low- and
high- (NP15) and high-only (NP4) affinity were
determined by ELISpot in the spleen of challenged
and boosted mice.
(J) Serum NP-specific Ab titers were determined
by ELISA. WT and Cxcr4+/1013 mice were bled
every week after immunization with NP-KLH. Both
low- and high- (NP15, left panels) and high-only
(NP4, right panels) affinity NP-specific IgG1 were
measured.
(K) Sera from WT and Cxcr4+/1013 mice were
collected after primary and secondary OVA im-
munizations and analyzed by ELISA for OVA-
specific IgG titers.
AU, arbitrary unit. Results are from three inde-
pendent experiments (mean ± SEM, n = 4–6, B–D
and F–K) or representative of one out of four in-
dependent determinations (E). *p < 0.05 and **p <
0.005, as compared with WT cells. See also Fig-
ures S2 and S3.in spot surface in ELISpot assays (Figure S3A). As for AFCs, the
affinity maturation of circulating NP-specific IgG1 was compara-
ble between WT and mutant mice (Figure 3J). Mirroring the
increased number of NP-specific AFCs observed after boost
(Figure 3I), the serum titers of high- and low-affinity NP-specific
IgG1 were increased 7 days after secondary immunization in
Cxcr4+/1013 mice (Figure 3J). Moreover, the number of memory
B cells defined as B220+CD73+CD38+ was preserved or even
increased, respectively, in the spleen and BM of boosted
Cxcr4+/1013 mice (Figures S3C and S3D).Taken together, these findings show that despite splenic follic-
ular hypoplasia, Cxcr4+/1013 mice mount an enhanced adaptive
immune response compared toWTmice characterized by normal
formation ofGCBcells, increasedproduction of IgG1NP-specific
AFCs, and a potent memory response after recall. However, in
absence of Cxcr4 desensitization, the Ag-specific Ab titers do
not reflect the enhanced local immune response observed in the
spleenandLNs, and thisdoesnot appear tobecausedbyadefect
in Ab secretion or PCmislocalization, nor is dependent on the Ag,
the adjuvant or the route of immunization used.Cell Reports 17, 193–205, September 27, 2016 197
Figure 4. The Deregulation of the Humoral
Immunity in Cxcr4+/1013 Mice Is B Cell
Autonomous
(A) Representative diagram of the chimera gener-
ation, immunization protocol, and experimental
time points.
(B) Quantification of CD45.2+ total B cells, GC
(B220+FAShighGL7high) B cells, NP-specific GC
B cells, and ratio of GC B cells to total B cells in
the spleen of WT and Cxcr4+/1013 BM chimeras
7 days after secondary immunization (boost) with
NP-KLH.
(C) Quantification of splenic CD45.2+ PCs (B220low
CD138high) in boosted WT and Cxcr4+/1013 BM
chimeras.
(D) Frequencies of NP-specific AFCs of low- and
high- (NP15) and high-only (NP4) affinity were
determined by ELISpot in the spleen of boosted
chimera mice.
(E) Serum NP-specific Ab titers were determined
by ELISA every week after primary immunization
and 7 days after boosting with NP-KLH in WT and
Cxcr4+/1013 BM chimeras.
Results (mean ± SEM, n = 4–6) are from three in-
dependent experiments. *p < 0.05 and **p < 0.005
compared with donor CD45.2+ WT cells. See also
Figures S1 and S3.The Deregulation of the Humoral Immunity in
Cxcr4+/1013 Mice is B Cell Autonomous
An important question was whether the enhanced immune
response observed in Cxcr4+/1013mice following TD Ag immuni-
zation was intrinsic to a gain of Cxcr4 function in B cells. We thus
generated BM chimeras as in Figure 1B. After reconstitution,
mice were immunized with NP-KLH precipitated in Alum and
boosted 35 days later with NP-KLH only (Figure 4A). After boost-
ing, the splenic B cell lymphopenia was still observed in mice
reconstituted with Cxcr4+/1013 BM (Figure 4B, left panel). Simi-
larly to full mice (Figure 3), the number of GC B cells was un-
changed betweenWT andCxcr4+/1013BM chimeras but the ratio
of GCB cells to total splenic B cells was significantly increased in
Cxcr4+/1013 BM chimeras compared to WT chimeras (Figure 4B,
middle panels). The number of NP-specific GC B cells was also
comparable between Cxcr4+/1013 and WT BM chimeras (Fig-
ure 4B, right panel). The numbers of both Tfh and Tfr cells
were identical between the two experimental conditions (data
not shown). The total number of PCs was not significantly
different (Figure 4C), but NP-specific IgG1 AFCs of both low
and high affinity were increased in the spleen of Cxcr4+/1013
BM chimera (Figure 4D). The surface of the spots was equivalent
between WT and Cxcr4+/1013 BM chimera (Figure S3B). We also198 Cell Reports 17, 193–205, September 27, 2016performed BM chimeras with mMT mice
as recipients and immunized them with
NP-KLH (Figures S1C and S1E). In this
system, a normal number of GC B cells,
an increased ratio of GC B cells to total
splenic B cells as well as a slight, albeit
not significant, increased number of PCs
were observed in immunized Cxcr4+/1013
BM-chimeric mice. These findings indi-cate that the enhanced PC generation observed in Cxcr4+/1013
mice upon immunization is due to a B cell-intrinsic gain of
Cxcr4 function.
Although the serum titer of NP-specific IgG1 was comparable
between experimental groups 7 days after primary immuniza-
tion, from day 14 it was lower for both low- and high-affinity
Abs in Cxcr4+/1013 BM chimeras compared to controls (Fig-
ure 4E). Following secondary immunization with NP-KLH only,
the Cxcr4+/1013 BM chimeras were able to mount a memory im-
mune response comparable to the one observed in WT BM chi-
meras (Figure 4E), despite the enhanced number of NP-specific
PCs detected in the spleen and the enhanced number ofmemory
B cell observed in the spleen and BM (Figure S3E). Taken
together, these findings suggest that Cxcr4 desensitization is
intrinsically required for efficient differentiation or trafficking of
long-lived PC.
In Vitro PC Differentiation Is Enhanced in Absence of
Cxcr4 Desensitization
To understand the molecular and cellular mechanisms under-
lying the increased PC generation in the secondary LOs of
Cxcr4+/1013 mice, we first examined the Cxcl12/Cxcr4 signaling
axis. Membrane expression levels of Cxcr4 were similar between
Figure 5. Enhanced Akt Signaling and PC
Differentiation in Cxcr4+/1013 B Cells
(A) Splenocytes pre-incubated or not with
AMD3100 were stimulated ex vivo with a F(ab’)2
goat anti-mouse IgM and/or Cxcl12 and the
mean fluorescence intensity (MFI) of phospho-
Syk, -Blnk, and -Akt was determined by flow cy-
tometry. Graphs indicate the MFI of the three
phosphoproteins in B220+ B cells.
(B) The frequency of live (Annexin V– PI–) CD19+
B cells was determined by flow cytometry after
stimulation for 2 days with a F(ab’)2 goat anti-
mouse IgM and/or Cxcl12.
(C) Expression levels of Mcl-1 and Bax in splenic
B cells stimulated for 4 days with a F(ab’)2 goat
anti-mouse IgMand/or Cxcl12were determined by
qRT-PCR. Expression levels were normalized to
the level of Actb transcripts. The fold change
compared to WT B cell expression is shown.
(D–F) Splenic WT and Cxcr4+/1013 B cells were
cultured with 1 U/ml IL-4 and 5 ng/ml IL-5 and
stimulated as in (C). (D) The proportion of PCs was
determined after 4 and 6 days of culture by flow
cytometry. (E) The expression levels of Xbp1, Irf4
and Prdm1 were assessed by qRT-PCR after
4 days of culture. (F) IgM concentration in B cell
culture supernatants wasmeasured by ELISA after
6 days of culture. Results (mean ± SEM, n = 3 to 6)
are from at least two independent experiments.
*p < 0.05 and **p < 0.005 compared with WT cells.
See also Figure S4.splenic WT and Cxcr4+/1013 B cells (data not shown), as previ-
ously reported (Balabanian et al., 2012). However, Cxcr4+/1013
B cells displayed impaired Cxcr4 internalization following
Cxcl12 stimulation and increased Cxcl12-promoted chemotaxis
that was abolished by the specific Cxcr4 antagonist AMD3100
(Figures S4A and S4B). These dysfunctions likely rely on the
altered signaling properties of the truncated Cxcr4 receptor as
revealed by Erk1/2 phosphorylation kinetics (Figure S4C). In
Cxcr4+/1013 B cells, Erk1/2 activation was strongly increased
at 1 min and persisted at longer time points, recapitulating and
extending observations we made in patient-derived cellsCell Rep(Lagane et al., 2008). Second, we as-
sessedwhether the gain of Cxcr4 function
affected BCR signaling. Wemeasured the
phosphorylation of the kinases Syk and
Blnk, two adaptors of the BCR but not
of Cxcr4 signaling pathways (Campbell,
1999; Guinamard et al., 1999). After BCR
cross-linking, there was increased phos-
phorylation of both kinases compared to
unstimulated B cells, regardless of the
Cxcr4 genotype, and this was not altered
further by the presence of Cxcl12 or upon
AMD3100 treatment (Figure 5A). Akt is
activated by both the BCR and CXCR4
signaling pathways (Kijowski et al., 2001;
Pogue et al., 2000).Cxcr4+/1013B cells ex-
hibited a much stronger phosphorylationof Akt than their WT counterparts after Cxcl12 stimulation, with
and without BCR crosslinking (Figure 5A). This effect was abro-
gated by pre-incubation with AMD3100. These results suggest
that the gain of Cxcr4 function does not modify signaling through
the BCR per se but may enhance signaling through a pathway
shared by both Cxcr4 and the BCR converging on Akt.
Signaling through Akt promotes cell survival but also plasma-
blast differentiation in vitro (Calamito et al., 2010; Omori et al.,
2006; Pogue et al., 2000; Suzuki et al., 2003). Survival of B cells
from WT and Cxcr4+/1013 mice was similar after 2-day culture in
the presence of BCR cross-linking, Cxcl12 or both, as measuredorts 17, 193–205, September 27, 2016 199
Figure 6. Altered Representation of PCs in the BM of Cxcr4+/1013 Mice
(A) Representative dot plots for the gating of fully differentiated PCs (CD138highB220–) and immature PCs (CD138highB220low) in the BM.
(B) Quantification of fully differentiated and immature PCs in the BMofWT andCxcr4+/1013mice 9 days (D9) after primary immunization and 7 days after secondary
immunization (Boost) with NP-KLH.
(C) Representative histograms for the expression of intracellular Igk and Ki-67 in CD138highB220– (red) and CD138highB220low (blue) PCs.
(D) Frequency of NP-specific IgG1 AFCs binding to NP with both low and high affinity (NP15) was determined by ELISpot in the BM of boosted mice.
(E) Representative diagram of the chimera generation, immunization protocol, and experimental time points.
(F) Quantification of CD138highB220- and CD138highB220low cells in the BM of boosted WT and Cxcr4+/1013 BM chimeras.
(G) Frequency of NP-specific IgG1 AFCs binding to NP with both low and high affinity (NP15) was determined by ELISpot in the BM of WT and Cxcr4+/1013 BM
chimera mice 7 days after secondary immunization (Boost) with NP-KLH.
Results are from three independent experiments (mean ± SEM, n = 6, B, D, F, and G) or representative of one experiment out of six independent determinations
(A and C). *p < 0.05 compared with WT or donor CD45.2+ WT cells. See also Figure S5.by the frequency of Annexin V– and Propidium Iodide– B cells
(Figure 5B). Furthermore, there was no imbalance in the expres-
sion of the pro-survival (Mcl1) and pro-apoptotic (Bax) factors af-
ter a 4-day culture (Figure 5C), arguing against a significant effect
of the gain of Cxcr4 function on the survival of B cells in vitro.
Finally, we studied the effect of a gain-of-function Cxcr4 muta-
tion on plasmablast differentiation in vitro. Splenic B cells were
cultured for up to 6 days in presence of a BCR cross-linking
Ab, Cxcl12 or both. The percentage of plasmablasts was signif-
icantly increased at day 4 in all conditions in Cxcr4+/1013 B cells
compared to WT cells (Figure 5D). At day 6, there were more
Cxcr4+/1013 plasmablasts only in the presence of BCR cross-link-
ing. In line with the results at day 4, expression levels of PC tran-
scriptional regulators, such as Xbp1, Irf4, and Prdm1, were
increased in Cxcr4+/1013 compared to WT B cells (Figure 5E).
We also detected increased IgM levels in the supernatants of
Cxcr4+/1013 B cells cultured for 6 days (Figure 5F). Altogether,200 Cell Reports 17, 193–205, September 27, 2016these results show that upon Cxcl12 exposure, the gain-of-
Cxcr4-function mutation leads to increased Akt signaling in B
cells and promotes PC differentiation.
Ag-Specific PCs Are Dramatically Reduced in the BM of
Cxcr4+/1013 Mice
Following their generation in secondary LOs, some PCs migrate
to the BM where they fully differentiate into long-lived PCs (Rad-
bruch et al., 2006). The BM homing of PCs is thought to rely at
least in part on the interaction between Cxcr4 and its ligand
Cxcl12, which is expressed on BM stromal cells (Hargreaves
et al., 2001; Sugiyama et al., 2006). We thus reasoned that a
gain-of-function mutation in Cxcr4might enhance PC trafficking
to the BM. In support of this, we observed a slight increase in the
number of total PCs (CD138highB220–) in the BM of Cxcr4+/1013
mice compared to WT littermates (Figures 6A–6C). However,
7 days after a boost, NP-specific AFCs were barely detectable
in the BM of Cxcr4+/1013 mice, while clearly present in the BM of
WT mice (Figure 6D). Instead, the BM of mutant but not of WT
mice contained a population of cells expressing CD138 and
low levels of B220 (Figures 6A and 6B), a phenotypemore usually
seen on splenic immature PCs (Figure 3H; Kallies et al., 2004)).
To confirm that these CD138highB220low cells were indeed
immature PCs, we showed that they had high levels of intracel-
lular Igk (Figure 6C, left panel) and that contrary to fully differen-
tiated PCs, they also expressed high levels of Ki-67 (Figure 6C,
right panel), indicating that they were still in cycle. A similar result
was observed in the BM of immunized Cxcr4+/1013 BM chimera
with barely detectable NP-specific IgG1 AFCs, increased num-
ber of total PCs, and the presence of the same aberrant popula-
tion of immature PCs (Figures 6E–6G). We wondered whether
this altered representation was caused by a change in PC
survival within the BM, a process that was reported to be under
the control of TRAIL-dependent apoptosis (Ursini-Siegel et al.,
2002). However, no difference in the expression of Trail
was observed in WT and mutant BM (Figure S5A). Cytokines
including interleukin-6 (IL-6), BAFF, and APRIL expressed in
the BM notably by eosinophils were also shown to modulate
PC persistence (Chu et al., 2011; Winter et al., 2010). Expression
levels of these cytokines aswell as the absolute number of eosin-
ophils and APRIL+ eosinophils were similar in WT and mutant
mice (Figures S5A–S5D). Thus, enhanced Ag-specific PC gener-
ation in the spleen does not translate into increased Ag-specific
PCs in the BM, which may explain the defective maintenance of
protective Ab titers over time. Furthermore, an aberrant popula-
tion of immature PCs accumulates in the BM in absence of Cxcr4
desensitization, potentially impacting the homing or mainte-
nance of Ag specific long-lived PCs.
Cxcr4 Desensitization Prevents the Accumulation of
Immature PCs in the BM
Aforementioned findings prompted us to assess the kinetics of
generation and appearance of immature PCs and NP-specific
AFCs in the spleen and BM of Cxcr4+/1013 mice. To this end,
WT and Cxcr4+/1013 mice were immunized intraperitoneally
with NP-KLH in alum and sacrificed at days 3, 6, 9, and 18 (Fig-
ure 7A). As previously shown, the number of total B cells was
reduced in the spleen of Cxcr4+/1013 mice compared to control
at all time points analyzed (Figure 7B). In line with this profound
splenic hypoplasia, the total number of GC B cells was also
reduced in mutant mice (Figure 7C), although their frequency
and kinetic of formation were normal (Figure 7D). Finally, the ratio
of GC B cells/B cells increased over time and from day 9 was
higher in absence of Cxcr4 desensitization (Figure 7E). Alto-
gether, these results suggest that despite the lymphopenia, the
GC form normally in the spleen of the mutant mice. At day 3,
the number of total PCs increased transiently in the spleen of
Cxcr4+/1013 mice (Figure 7F). Strikingly, immature PCs were de-
tected in the BM of mutant mice from day 3 post-immunization,
their number increasing until day 9 before slightly decreasing at
day 18 (Figure 7G). The number of fully differentiated PCs was
starting to increase from day 6 in the BMofCxcr4+/1013mice (Fig-
ure 7H). Finally, we evaluated the generation of Ag-specific AFCs
by ELISpot and confirmed enhanced detection of NP-specific
IgG1 AFCs in the spleen of Cxcr4+/1013 mice at day 9 (Figure 7I).In contrast, such cells were barely detectable in the BM of
mutant mice at all time points tested (Figure 7J), arguing against
a delayed homing to the BM. Therefore, in absence of Cxcr4
desensitization, immature PCs may accumulate very early after
primary immunization in the BM, while Ag-specific PCs that are
generated later fail to home and persist in this tissue.
DISCUSSION
CXCR4 is known to play an important role in the regulation of B
cell homeostasis and activation. However, most of our current
knowledge is based on loss-of-function studies using genetic
mouse models or pharmacological inhibitors (Beck et al., 2014;
Ma et al., 1998, 1999; Nie et al., 2004). In this study, we investi-
gated the role of Cxcr4 on the B cell response to TD Ags using a
unique mouse model with a naturally occurring heterozygous
gain-of-function mutation (Cxcr4+/1013). We report that increased
Cxcr4 signaling promotes B cell activation and differentiation but
interestingly does not facilitate the generation of long-term Ab ti-
ters against TD Ags. Despite a marked peripheral B cell lympho-
penia and distorted LN architecture, immunized Cxcr4+/1013
mice displayed increased frequency and number of Ag-specific
PCs in the spleen and LNs irrespective of the Ag, the adjuvant or
the route of immunization used. Thismay rely partly on enhanced
Cxcr4-mediated signaling through Akt and increased PC differ-
entiation. However, and counter-intuitively, Ag-specific PCs
failed to accumulate in the BM and Ag-specific serum Ab titers
were not maintained over time. Long-term BM chimera experi-
ments confirmed the B cell intrinsic nature of the identified
defects.
Splenic architecture was not affected by the gain of Cxcr4
function, but the size and number of the lymphoid follicles
were greatly reduced (Balabanian et al., 2012). Despite this pro-
found hypoplasia, surprisingly the number of GC B cells was
normal in the immunized mutant mice. Cxcr4 is pivotal for cen-
troblast localization in the dark zone (Allen et al., 2004; Bannard
et al., 2013), where Cxcl12-expressing reticular cells have
been recently identified (Rodda et al., 2015). Accordingly, we
observed an increased centroblast/centrocyte ratio in the spleen
of immunizedCxcr4+/1013mice. Although GCB cells can prolifer-
ate in both light and dark zones (Bannard et al., 2013), dark zone
centroblasts divide more rapidly than centrocytes (Gitlin et al.,
2014; Victora et al., 2010), and proliferation is partly impaired in
Cxcr4-deficient GC B cells (Bannard et al., 2013). One can spec-
ulate that a minor increase in the proliferation rate of Cxcr4+/1013
GCBcells in the dark zonemight account for the normalization of
their number compared to WT cells. Despite the enhanced cen-
troblast/centrocyte ratio in Cxcr4+/1013 mice, affinity maturation
was normal implying that selection of high-affinity clones was
not altered (Gitlin et al., 2014, 2015). In line with this, Tfh and
Tfr numbers were unchanged in the spleen and LNs of the
mutant mice compared toWT littermates, although their function
has not been formally assessed. Upon secondary challenge with
a TD Ag, memory B cells are thought to respond rapidly and
differentiate into plasmablasts (Ochsenbein et al., 2000). Our
data suggest this process occurs efficiently in Cxcr4+/1013 mice
as we observed normal and increased numbers of memory B
cells in the spleen and BM respectively. Moreover, increasedCell Reports 17, 193–205, September 27, 2016 201
Figure 7. Kinetics of Generation and
Appearance of PCs in the Spleen and BM
of Cxcr4+/1013 Mice
(A) Representative diagram of the immunization
protocol and experimental time points.
(B and C) Quantification of total B cells (B220+, B)
and GC B cells (B220+FAShighGL7high, C) in the
spleen of WT and Cxcr4+/1013mice 3 (D3), 6 (D6), 9
(D9), and 18 (D18) days after primary immunization
with NP-KLH.
(D and E) Frequency of GC B cells among total B
cells (D) and ratio of GCB cells over total B cells (E)
in the spleen of immunized WT and Cxcr4+/1013
mice.
(F) Quantification of PCs (CD138highB220low) in the
spleen of immunized WT and Cxcr4+/1013 mice.
(G and H) Quantification of immature PCs
(CD138highB220low, G) and fully differentiated PCs
(CD138highB220–, H) in the BM of immunized WT
and Cxcr4+/1013 mice.
(I and J) Frequencies of NP-specific IgG1 AFCs of
low and high (NP15) affinity were determined by
ELISpot in the spleen (I) and BM (J) of immunized
mice.
Results (mean ± SEM, nR 3) are representative of
one out of two (I and J) or three (B–H) independent
experiments.splenic NP-specific AFC numbers and serum titers of high- and
low-affinity NP-specific IgG1 were observed 1 week after boost-
ing with NP-KLH alone.
Mechanistically, we showed that Cxcr4 signaling, together
with cross-linking of the BCR, promotes the phosphorylation of
Akt in B cells from Cxcr4+/1013 mice, and this may account for
the enhanced PC number and in vitro differentiation we observed
(Omori et al., 2006; Suzuki et al., 2003). Quantification of splenic
or LN AFCs by ELISpot revealed an increase in Ag-specific AFCs
in immunized Cxcr4+/1013 mice regardless of the time point and
without a detectable difference in spot size, thus suggesting202 Cell Reports 17, 193–205, September 27, 2016that the capacity of Cxcr4+/1013 PCs to
secrete Ab was preserved. Supporting
this, we found in vitro that Cxcl12 with
or without BCR cross-linking enhanced
PC differentiation of splenic Cxcr4+/1013
B cells and that this was associated with
production and secretion of Abs. How-
ever, enhanced differentiation of PCs in
secondary LOs did not translate in an
increased level of circulating NP-specific
Abs, and this was even associated with
a progressive decrease of specific Ab
titer over time.
The defect in circulating Ab could
be explained by the strong reduction in
NP-specific PCs observed in the BM of
immunized Cxcr4+/1013 mice. It appears
that in absence of Cxcr4 desensitization
and despite the increase in total PCs
in the BM, newly generated Ag-specific
PCs fail to reach the BM of Cxcr4+/1013mice. One question arising from our findings pertains to the
mechanism underpinning defective detection of NP-specific
PCs in the BM of mutant mice. Several overlapping possibilities
could explain this. First, PCs generated in the spleen and LN of
Cxcr4+/1013 mice may fail to differentiate into long-term PCs,
thus explaining the rapid decrease in NP-specific Ab titers.
Somewhat against this hypothesis is the fact that the number
of fully differentiated PCs in the BM is normal or even increased
at different time points after primary and secondary immuniza-
tions. Second, NP-specific PCs may be unable to effectively
egress from secondary LOs. Indeed, Cxcr4 is involved in B cell
and PC entry to and retention within the spleen red pulp and LN
medulla, which are both reported to express Cxcl12 (Hargreaves
et al., 2001; Nakai et al., 2014; Nie et al., 2004). As such, the gain
of Cxcr4 function might lead to an aberrant retention of newly
generated PCs in the LN and the spleen. However, our findings
do not support this hypothesis as PC localization in the spleen
was normal and PCs did not accumulate in this organ with
time. Third, the gain of Cxcr4 function may alter the homing of
NP-specific PCs to the BM. Cxcr4 is known to participate in
the homing of newly generated PCs to the BM (Hargreaves
et al., 2001; Hauser et al., 2002). A fraction of these PCs are re-
tained and differentiate into fully mature PCs that survive for long
periods of time in highly specialized niches that are not yet fully
defined. Our results suggest that some Cxcr4+/1013 PCs are
able to migrate to the BM as we found a slight increased number
of long-lived PC in the BM of mutant mice. Under-representation
of Ag-specific PCs in the BMwas observed from day 3 to day 18
after primary immunization and 3 months after boost (data not
shown), thus ruling out a delay in BM migration of Cxcr4+/1013
NP-specific PCs from the periphery. Our findings further suggest
that the altered representation of NP-specific PCs is unlikely to
be caused by defects in cytokine production or cellular sources
in the BM. Finally, we identified an unusual population of PCs dis-
playing an immature, highly proliferative phenotype similar to
that of splenic plasmablasts that abnormally accumulate very
rapidly in the BM of immunized mutant mice. These cells may
occupy BM niches normally dedicated to GC-derived Ag-spe-
cific PCs. Consequently the lodging of Ag-specific PCs could
be altered due to mis-localization in the BM and subsequent
lack of appropriate survival and nursing signals required for their
maturation and maintenance. Altogether, our results support a
model where Cxcr4 desensitization is a critical mechanism con-
trolling which PCs home and persist within the BM.
Mice deficient for the gene encoding the transcription factor
c-Myb display a similar phenotype to the one of Cxcr4+/1013
mice, namely, a lack of Ag-specific PCs in the BMdespite normal
GC reaction and AFC production in the spleen post-immuniza-
tion (Good-Jacobson et al., 2015). This was related to an inability
of c-Myb-deficient PCs to migrate in response to Cxcl12. This
loss-of-Cxcr4-function was not secondary to modulation of the
membrane receptor, suggesting that c-Myb regulates respon-
siveness to Cxcl12 downstream of Cxcr4 and also plays a role
in controlling the migration of PCs from secondary LOs to the
BM. Combined with our findings, these results suggest that
both increased and decreased Cxcr4-mediated signaling have
similar effects on the trafficking of Ag-specific PCs between sec-
ondary LOs and the BM. Together they indicate that fine-tuning
of Cxcr4 signaling is critical for the production of Ag-specific PCs
in secondary LOs during a TD response and subsequently for
their egress and homing to the BM and for the establishment
of a stable resident PC pool for long-term protective humoral
immunity.
Our observations are directly relevant to WS patients. Hypo-
gammaglobulinemia constitutes a variable feature of WS with
moderate deficiency of Igs seen in some but not all patients.
They exhibit efficient primary responses following immune
challenges, but their serum Ag-specific Ab titers appear to
decline rapidly (Gulino et al., 2004; Handisurya et al., 2010;Mc Guire et al., 2010; Tassone et al., 2009). For instance, in
one study patients immunized with tetanus toxoid produce
normal amounts of specific Abs 10 weeks after immunization,
but no specific Ab was detectable at 1 year. This mirrors the
phenotype of the Cxcr4+/1013 mice, and our data would sug-
gest that this reflects a defect in long-lived PC response and
needs to be taken into account in managing this group of
patients.
EXPERIMENTAL PROCEDURES
Mice and Immunization
Mice were immunized with 100 mg of either OVA adjuvanted with SAS (Sigma-
Aldrich) or 4-hydroxy-3-nitrophenylaceyl-keyhole limpet hemocyanine (NP-
KLH) (Biosearch Technologies) adjuvanted with Alum (Thermo Scientific).
Blood, spleen, BM, and inguinal LNs were harvested at the indicated time
points and single-cell suspension were prepared. All experiments were con-
ducted in compliance with the European Union guide for the care and use of
laboratory animals and has been reviewed and approved by an appropriate
institutional review committee (C2EA-26, Animal Care and Use Committee,
Villejuif, France).
In Vitro Functional Assays
For apoptosis assays, splenocytes were stimulated with a F(ab’)2 goat
anti-mouse IgM (Jackson ImmunoResearch) at 10 mg/mL and/or Cxcl12
(R&D Systems) at 50 nM during 2 days at 37C. For PC differentiation and
qRT-PCR, B cells were isolated from total splenocytes using a mouse B cell
isolation kit (Miltenyi Biotec) and stimulated with 1 U/mL of IL-4 (Miltenyi)
and 5 ng/mL IL-5 (Miltenyi) supplemented with 10 mg/mL F(ab’)2 goat anti-
mouse IgM and 80 ng/mL CD40L (PeproTech) and/or 50 nM Cxcl12 during
4 or 6 days at 37C.
Flow Cytometry
Single-cell suspensions were stained using the Abs described in the supple-
mental experimental procedures. NP conjugated to phycoerythrin (PE) was
from Biosearch Technologies. OVA-FITC conjugate was purchased from Invi-
trogen. For phosphoflow analyses, splenocytes were pre-incubated in RPMI
only with or without 10 mM of AMD3100 (Sigma) before being stimulated
with 10 mg/ml of F(ab’)2 goat anti-mouse IgM and/or 50 nM Cxcl12 during
5 min at 37C.
qRT-PCR
qPCRs were performed on a Light Cycler instrument (LC480, Roche Diagnos-
tics) with the LightCycler 480 SYBRGreen detection kit (Roche Diagnostics) or
TaqMan chemistry (Applied Biosystems) using the primers listed in the supple-
mental experimental procedures. b-actin (Actb) was used as the reference
standard for normalization, except for Il-6 and Trail (normalized with Gapdh),
and relative quantification of fold differences in mRNA expression was deter-
mined by the comparative delta-delta-ct (2DDCT) method.
Immunofluorescence
LNs and spleens cryosections were stained with different combinations of Abs
detailed in the supplemental experimental procedures. Slides were scanned
using a NanoZoomer Digital Pathology system using 23, 103, or 303 objec-
tive lenses with numerical aperture 0.75 (Hamamatsu Photonic).
ELISA and ELISpot
Serum anti-OVA IgG1 or anti-NP IgG1 titers were determined by ELISA, as
previously described (Natt and Espe´li, 2015). In differentiation assays, culture
supernatants were incubated on wells pre-coated with 5 mg/ml of goat
anti-mouse IgM (Jackson ImmunoResearch) and saturated and then incubated
with peroxidase-conjugated goat anti-mouse IgM (SouthernBiotech). Enumer-
ation of OVA- and NP-specific AFCs was performed by ELISpot assays from
5 3 105 inguinal LN cells or 1 3 105 spleen or BM cells per well, respectively,
as previously described (Espe´li et al., 2012; Pelletier et al., 2010).Cell Reports 17, 193–205, September 27, 2016 203
Statistical Analyses
Data are expressed as means ± SEM. The statistical significance between
groups was evaluated using the two-tailed Student’s t test (phosphoflow ana-
lyses) or the two-tailed unpaired Mann-Whitney non-parametric test for all
other experiments (Prism software, GraphPad).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.08.068.
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